SOURCE: Industrial Info Resources

Industrial Info Resources

June 12, 2012 06:20 ET

Pharma-Biotech Capital Construction Investment Mid-Year Snapshot: 2012 Project Starts Near $15 Billion, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwire - Jun 12, 2012) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- With 2012 almost halfway complete, the North American Pharmaceutical-Biotech Industry is holding its own. In January 2012, the industry as a whole had more than $17 billion in reported capital and maintenance projects scheduled to kick off throughout the year. Six months later, that total has dropped to just less $15 billion, or $14.7 billion to be exact.

Other companies featured Baxter International Corporation (NYSE:BAX), Abbott Laboratories (NYSE:ABT)

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at, or browse other breaking industrial news stories at

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "Contact Us" page.

Contact Information

  • Contact:
    Joe Govreau